FindTrial
Sign In

Study on the postoperative analgesic effect of quadratus lumborum block combined with transcutaneous electrical acupoint stimulation in pediatric lower abdominal laparoscopic surgery

Study on the postoperative analgesic effect of quadratus lumborum block combined with transcutaneous electrical acupoint stimulation in pediatric lower abdominal laparoscopic surgery

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ITMCTR
Registry ID
ITMCTR2025000024
Enrollment
Unknown
Registered
2025-01-07
Start date
2025-02-01
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

postoperative analgesia

Interventions

Intravenous analgesia + quadratus lumborum block + transcutaneous electrical acupoint stimulation group (group QT):The bilateral Hegu (LI4) and Neiguan (PC6) acupoints are stimulated starting from 10
Intravenous analgesia + transcutaneous electrical acupoint stimulation group (group T):The bilateral Hegu (LI4) and Neiguan (PC6) acupoints are stimulated starting from 10 min before anesthetic induct
Intravenous analgesia group (Control group):Sufentanil (0.1 µg/kg) is given intravenously at the end of the last stitch
Intravenous analgesia + quadratus lumborum block group (group Q):The bilateral quadratus lumborum block is performed 10 min before incision and sufentanil (0.1 µg/kg) is given intravenously at the en

Sponsors

Zhongnan Hospital of Wuhan University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
3 Years to 16 Years

Inclusion criteria

Inclusion criteria: Children aged 3–16 years who are scheduled to undergo lower abdominal laparoscopic surgery under general anesthesia (grade 1–2 according to the definitions of the American Society of Anesthesiologists) with consent of the parents or guardians in writing.

Exclusion criteria

Exclusion criteria: (1) children who are known allergies to local anesthetics; (2) children with severe heart or respiratory or renal or liver disease; (3) children with local or systematic infection; (4) children withcoagulation disorders; (5) children with emergency surgery or history of abdominal surgery; (6) children with electronic devices in the body or injured skin at the sites of stimulation; (7) children who were prescribed long-term opioids for chronic pain; (8) children who had ever received TEAS or acupuncture; (9) children with cognitive impairment

Design outcomes

Primary

MeasureTime frame
the Face Legs Activity Cry and Consolability (FLACC) score at 30min 1h 4?h 8?h 12?h and 24?h;tramadol consumption within 24h postoperatively;—

Secondary

MeasureTime frame
the number of children received tramadol;time to the frst tramadol request;postoperative adverse reactions;—

Countries

China

Contacts

Public ContactWU Yun

Zhongnan Hospital of Wuhan University

ZN000441@whu.edu.cn180 7112 1132

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Feb 4, 2026